Gemcitabine, Busulfan and Melphalan (GemBuMel) Is a New High-Dose Chemotherapy (HDC) Regimen with High Activity In Refractory Hodgkin's Lymphoma (HL) Patients Receiving An Autologous Stem-Cell Transplant (ASCT): A Contemporaneous Comparison with BEAM and Busulfan/Melphalan (BuMel)

被引：3
|
作者：
Nieto, Yago [1 ]
Anderlini, Paolo [1 ]
Popat, Uday [1 ]
Liu, Ping [1 ]
Andersson, Borje S. [1 ]
Shpall, Elizabeth J. [1 ]
Kebriaei, Partow [1 ]
Hosing, Chitra [1 ]
Alousi, Amin M. [1 ]
Qazilbash, Muzaffar H. [1 ]
Ciurea, Stefan O. [1 ]
Parmar, Simrit [1 ]
Champlin, Richard E. [1 ]
Jones, Roy [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
BLOOD | 2010年 / 116卷 / 21期
关键词：
D O I：
10.1182/blood.V116.21.690.690
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：304 / 304
页数：1
相关论文
共 50 条
  • [1] PHASE 2 TRIAL OF HIGH-DOSE GEMCITABINE, BUSULFAN AND MELPHALAN WITH AUTOLOGOUS STEM CELL TRANSPLANT (ASCT) FOR PATIENTS WITH REFRACTORY HODGKIN'S LYMPHOMA (HL)
    Nieto, Y.
    Popat, U.
    Anderlini, P.
    Hosing, C.
    Andersson, B.
    Valdez, B.
    Shpall, E. J.
    Ahmed, S.
    Qazilbash, M.
    Kebriaei, P.
    Alousi, A.
    Bassett, R.
    Oki, Y.
    Fanale, M.
    Hagemeister, F.
    Dabaja, B.
    Reed, V.
    Pinnix, C.
    Tewari, P.
    Worth, L.
    Champlin, R.
    Jones, R. B.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S166 - S166
  • [2] GEMCITABINE, BUSULFAN AND MELPHALAN (Gem/Bu/Mel) IS A NEW HIGH-DOSE CHEMOTHERAPY (HDC) REGIMEN WITH HIGH ACTIVITY IN REFRACTORY OR POOR-RISK RELAPSED NON-HODGKIN'S LYMPHOMA (NHL) PATIENTS RECEIVING AN AUTOLOGOUS STEM-CELL TRANSPLANT (ASCT)
    Nieto, Y.
    Jones, R. B.
    Popat, U.
    Andersson, B.
    Valdez, B.
    Thall, P.
    Shpall, E. J.
    Chancoco, C.
    Alousi, A.
    Anderlini, P.
    Hosing, C.
    Qazilbash, M.
    Bashir, Q.
    Kebriaei, P.
    Khoui, I
    Ciurea, S.
    Parmar, S.
    Rondon, G.
    Champlin, R.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S206 - S206
  • [3] COMPARISON OF GEMCITABINE, BUSULFAN AND MELPHALAN (Gem/Bu/Mel) WITH BEAM AND BUSULFAN/MELPHALAN (Bu/Mel) IN CONCURRENT COHORTS OF REFRACTORY HODGKIN'S LYMPHOMA (HL) PATIENTS RECEIVING AN AUTOLOGOUS STEM-CELL TRANSPLANT
    Nieto, Y.
    Jones, R. B.
    Liu, P.
    Anderlini, P.
    Popat, U.
    Andersson, B.
    Shpall, E. J.
    Alousi, A.
    Hosing, C.
    Kebriaei, P.
    Qazilbash, M.
    Frazier, E.
    Chancoco, C.
    Bashir, Q.
    Ciurea, S.
    Parmar, S.
    Champlin, R.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S206 - S207
  • [4] High-Dose Infusional Gemcitabine (Gem) Combined with Busulfan (Bu) and Melphalan (Mel) (GemBuMel) with Autologous Stem-Cell Transplant (ASCT) in Patients with Refractory Lymphoid Malignancies
    Nieto, Yago
    Thall, Peter F.
    Andersson, Borje S.
    Popat, Uday R.
    Anderlini, Paolo
    Valdez, Benigno C.
    Shpall, Elizabeth J.
    Qazilbash, Muzaffar
    Alousi, Amin M.
    Chancoco, Christina
    Hosing, Chitra M.
    Kebriaei, Partow
    Bashir, Qaiser
    Shah, Nina
    Khouri, Issa
    Ciurea, Stefan O.
    McMullin, Becky
    Rondon, Gabriela
    Champlin, Richard
    Jones, Roy
    BLOOD, 2011, 118 (21) : 1331 - 1332
  • [5] High-Dose Gemcitabine Combined With Busulfan and Melphalan (Gem/Bu/Mel) With Autologous Stem-Cell Transplant (ASCT) In Refractory and Relapsed Myeloma
    Nieto, Yago
    Shah, Nina
    Popat, Uday R.
    Jones, Roy B.
    Bashir, Qaiser
    Bassett, Rolland
    Valdez, Benigno C.
    Andersson, Bone S.
    Parmar, Simrit
    Orlowski, Robert Z.
    Shah, Jatin J.
    Thomas, Sheeba K.
    Wang, Michael
    Champlin, Richard E.
    Qazilbash, Muzaffar
    BLOOD, 2013, 122 (21)
  • [6] High-dose gemcitabine, busulfan, and melphalan for autologous stem-cell transplant in patients with relapsed or refractory myeloma: a phase 2 trial and matched-pair comparison with melphalan
    Nieto, Yago
    Valdez, Benigno C.
    Pingali, Sai R.
    Bassett, Roland
    Delgado, Ruby
    Nguyen, John
    Shah, Nina
    Popat, Uday
    Jones, Roy B.
    Andersson, Borje S.
    Gulbis, Alison
    Ahmed, Sairah
    Bashir, Qaiser
    Parmar, Simrit
    Patel, Krina
    Myers, Alan
    Rondon, Gabriela
    Orlowski, Robert Z.
    Champlin, Richard
    Qazilbash, Muzaffar
    LANCET HAEMATOLOGY, 2017, 4 (06): : E283 - E292
  • [7] Matched pair comparison of concurrent cohorts of patients with relapsed/refractory (R/R) myeloma receiving an autologous stem-cell transplant (ASCT) using gemcitabine/busulfan/melphalan (GemBuMel) or single-agent melphalan
    Nieto, Y.
    Milton, D.
    Pingali, R.
    Nguyen, J.
    Delgado, R.
    Valdez, B.
    Jones, R.
    Andersson, B.
    Shah, N.
    Bashir, Q.
    Patel, K.
    Popat, U.
    Parmar, S.
    Shah, J.
    Orlowski, R.
    Thomas, S.
    Manasanch, E.
    Weber, D.
    Wang, M.
    Rondon, G.
    Champlin, R.
    Qazilbash, M.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S16 - S17
  • [8] Vorinostat (SAHA) Combined With High-Dose Gemcitabine/Busulfan/Melphalan (SAHA/Gem/Bu/Mel) With Autologous Stem-Cell Transplant (ASCT) In Patients With Refractory Lymphomas
    Nieto, Yago
    Thall, Peter F.
    Valdez, Benigno C.
    Hosing, Chitra M.
    Ahmed, Sairah
    Jones, Roy B.
    Shah, Nina
    Anderlini, Paolo
    Qazilbash, Muzaffar H.
    Popat, Uday R.
    Bashir, Qaiser
    Shpall, Elizabeth J.
    Alousi, Amin
    Kebriaei, Partow
    Fox, Patricia
    Bassett, Rolland
    Chancoco, Christina
    Oki, Yasuhiro
    Fanale, Michelle A.
    Fowler, Nathan
    Hagemeister, Frederick
    Romaguera, Jorge E.
    Champlin, Richard E.
    Andersson, Borje S.
    BLOOD, 2013, 122 (21)
  • [9] High-Dose Infusional Gemcitabine Combined with Busulfan and Melphalan with Autologous Stem-Cell Transplantation in Patients with Refractory Lymphoid Malignancies
    Nieto, Yago
    Thall, Peter
    Valdez, Ben
    Andersson, Borje
    Popat, Uday
    Anderlini, Paolo
    Shpall, Elizabeth J.
    Bassett, Roland
    Alousi, Amin
    Hosing, Chitra
    Kebriaei, Partow
    Qazilbash, Muzaffar
    Frazier, Erin
    Gulbis, Alison
    Chancoco, Christina
    Bashir, Qaiser
    Ciurea, Stefan
    Khouri, Issa
    Parmar, Simrit
    Shah, Nina
    Worth, Laura
    Rondon, Gabriela
    Champlin, Richard
    Jones, Roy B.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (11) : 1677 - 1686
  • [10] Vorinostat Combined with High-Dose Gemcitabine, Busulfan, and Melphalan with Autologous Stem Cell Transplantation in Patients with Refractory Lymphomas
    Nieto, Yago
    Valdez, Benigno C.
    Thall, Peter F.
    Ahmed, Sairah
    Jones, Roy B.
    Hosing, Chitra
    Popat, Uday
    Shpall, Elizabeth J.
    Qazilbash, Muzaffar
    Gulbis, Alison
    Anderlini, Paolo
    Alousi, Amin
    Shah, Nina
    Bashir, Qaiser
    Liu, Yan
    Oki, Yasuhiro
    Hagemeister, Frederick
    Fanale, Michelle
    Dabaja, Bouthaina
    Pinnix, Chelsea
    Champlin, Richard
    Andersson, Borje S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (11) : 1914 - 1920
12345